A Tale of Two Studies
With increasing evidence that psychiatric drugs do more harm than good over the long term, the field of psychiatry often seems focused on sifting through the mounds of research data it has collected, eager to at last sit up and cry, here’s a shiny speck of gold! Our drugs do work! One recently published study on withdrawal of antipsychotics tells of long-term benefits. A second tells of long-term harm. Which one is convincing?
New Study Concludes that Antidepressants are “Largely Ineffective and Potentially Harmful”
A new study published in Frontiers in Psychiatry concludes that “antidepressants are largely ineffective and potentially harmful.”
Psychiatrists Warn Policymakers Benzodiazepine Overuse Could Lead to Next Epidemic
Although opioid addiction and overuse have garnered significant national attention, similar trends in benzodiazepine overprescription and overuse continue to go unnoticed.
Do Antidepressants Work? A People’s Review of the Evidence
After a meta-analysis of RCTs of antidepressants was published in Lancet, psychiatry stated that it proved that "antidepressants" work. However, effectiveness studies of real-world patients reveal the opposite: the medications increase the likelihood that patients will become chronically depressed, and disabled by the disorder.
Transcranial Electrical Stimulation Can’t Directly Alter Brain Patterns, Researchers Find
Due to the thickness of the scalp and skull, transcranial electrical stimulation (TES) is incapable of targeting networks of neurons in the brain.
Race and Class Affect Teacher Perceptions of ADHD Medication Use
Study uncovers teachers’ attitudes surrounding ADHD medication use and examines the influence of race and social class on teacher beliefs.
Researchers Challenge Industry-Friendly Depression Guideline
Review of a new mixed depression guideline reveals financial bias of guideline developers and lack of evidence supporting recommendations for prescribing of antipsychotics.
CDC Reports Increased Psychostimulant Prescriptions in Women of Reproductive Age
Psychostimulant prescriptions have increased by 344% (from 2003 to 2015) for women of reproductive age (15-44 years old).
Cognitive Impairment from Long-Term Benzodiazepine Use Remains Even After Drug Withdrawal
Long-term benzodiazepine use shown to effect cognitive function during current use and for years after drug discontinuation.
Researchers Expose Pharmaceutical Industry Misconduct and Corruption
Corruption of pharmaceutical industry sponsored clinical trials identified as a “major obstacle” facing evidence-based medicine.
Vitamin B6 Effective in Reducing Antipsychotic Induced Akathisia
A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.
Failed TB Vaccine Exposes Concerns Regarding Research Ethics
An investigation exposes violations to research ethics, finding that researchers failed to disclose risks and even misled government agencies.
Preventing Long-term Benzodiazepine Use
Researchers Identify risk factors for long-term benzodiazepine use to prevent harmful effects.
Reducing Antipsychotic Use May Improve Health for People with Mental Health Diagnoses
A new study offers radical solutions for improving the cardiovascular health of people with mental health diagnoses: reducing antipsychotic prescriptions..
Anticholinergic Medications Linked to Dementia Similar to Early Alzheimer’s
A new study, published in the Journal of Clinical Psychiatry, investigates the effects of anticholinergic medications, such as antidepressants and antipsychotics, on cognition in older adults diagnosed with schizophrenia.
Antidepressants During Pregnancy Increase Risk of Psychiatric Diagnosis in Children
New research, based on data from almost a million children in Denmark, suggests that children of mothers who use antidepressants during pregnancy are more likely to be diagnosed with autism and psychiatric disorders.
New Research on Prenatal SSRI Exposure and Autism
Does maternal SSRI exposure increase the chances that a child will develop characteristics associated with Autism Spectrum Disorder (ASD)?
Cognitive-Behavioral Therapy Halves the Risk of Repeated Suicide Attempts
A new study suggests that cognitive-behavioral therapy (CBT) may halve the likelihood of re-attempting suicide, for those who have attempted in the past.
Study Examines the Difficulty of Withdrawing from Antidepressant Drugs
Correcting unnecessary long-term antidepressant use is difficult and met with apprehension by providers and service-users.
Scientists Clarify Risks of Augmenting with Antipsychotic Medications for Depression
The researchers found that while antipsychotic drugs may be slightly more effective than alternative antidepressants, they come with a much higher side effect burden.
Children Diagnosed with ADHD Younger are More Likely to get Multiple Medications
New research demonstrates that children diagnosed with ADHD at younger ages are more likely than those diagnosed later to receive multiple medications within five years of their diagnosis.
Scientists Call for Increased Transparency in Research
Scientists at the Yale Collaboration for Research Integrity and Transparency (CRIT) published a new policy paper this month criticizing the current state of biomedical research and calling for improved transparency in research methods.
Patients on Antipsychotics at High Risk for Cardiovascular Issues, Study Finds
Antipsychotics present a known risk for major side effects. A new study suggests that certain antipsychotics may present a greater risk for cardiovascular disease than others.
Outcome Reporting Bias in Antipsychotic Medication Trials
A new study in the journal Translational Psychiatry, an influential journal in biological psychiatry published by Nature, challenges the state of the research on antipsychotic drugs.
Pharmaceutical Industry Gifts Linked to Costlier Prescribing Practices
New study finds that pharmaceutical industry gifts to medical providers in Washington D.C. are associated with higher cost, higher volume prescribing behavior.
